Pyridine → 3[2-(4-Ethyl-2,3-dioxopiperazine-1-carbonylamino)-2-phenylacetamido]-3-formamido-4-methylazetidin-2-one

HRID 2118560

Reaktionsgleichung

Reaktionsgleichung von HRID 2118560
[NH2:1][C:2]1([NH:8][C:9](=[O:30])[CH:10]([NH:17][C:18]([N:20]2[CH2:25][CH2:24][N:23]([CH2:26][CH3:27])[C:22](=[O:28])[C:21]2=[O:29])=[O:19])[C:11]2[CH:16]=[CH:15][CH:14]=[CH:13][CH:12]=2)[CH:5]([CH3:6])[NH:4][C:3]1=[O:7].N1C=CC=CC=1.[C:37](OC=O)(=[O:39])C>ClCCl>[CH2:26]([N:23]1[CH2:24][CH2:25][N:20]([C:18]([NH:17][CH:10]([C:11]2[CH:16]=[CH:15][CH:14]=[CH:13][CH:12]=2)[C:9]([NH:8][C:2]2([NH:1][CH:37]=[O:39])[CH:5]([CH3:6])[NH:4][C:3]2=[O:7])=[O:30])=[O:19])[C:21](=[O:29])[C:22]1=[O:28])[CH3:27]

Komponenten

5

Versuchsvorschrift

A solution of the amine (62) (87 mg) and pyridine (33 mg) in dry dichloromethane (2 ml) was treated with formic acetic anhydride (40 mg) for 24 hour after which time the solvent was removed in vacuo. Dry dioxan was added and solution re-evaporated (×3). Silica gel column chromatography of the residue gave the title compound (63) (80 mg) as a white powder, νmax. (Nujol) 3500, 3250, 1770, 1710, 1670, and 1500 cm-1, δ[(CD3)2CO] 0.88, 0.96, 1.00 and 1.03 (each d, J 6.5 Hz, together 3H) (irradiation at 4.00 caused the signals centered at 0.88 and 0.96 to collapse to 2×s), 1.16 (t, J7 Hz, 3H), 3.49(q, J7.Hz, 2H), 3.58-3.68 (m.2H), 3.93-4.23 (complex m, together 3H), 5.59-5.84 (complex m, together 1 H) (collapses to 4×s at 5.65, 5.69, 5.76 and 5.80 upon irradiation at 10.0), 7.25-7.80 (complex m, together 6H) (simplifies on exchange with D2O to a m at 7.25-7.56), 7.97-8.86 (complex m, together 3H) (simplifies to 4×s at 8.03, 8.11, 8.24, and 8.48 on exch.), 9.90-10.05 (m, 1H, exch).

Aufarbeitung

  1. customwas removed in vacuo
  2. additionDry dioxan was added
  3. customsolution re-evaporated (×3)

Quellen und Nachweise

ORD-Eintrag
ord-7fd4311c308e40b48b0f9f8db0de0d51
Quelldatensatz
uspto-grants-1987_07
Patentnummer
US04678782

Verknüpfte Notizen

Wird geladen…